Search
Zevra Therapeutics Inc
ZVRAAdd to Watchlist
12.140USD
+0.550+4.75%
Close 11-09 16:00（ET）
720.87MMarket Cap
5.75P/E TTM
Today
+4.75%
5 Days
+20.20%
1 Month
+6.58%
6 Months
+9.07%
Year to Date
+35.49%
1 Year
+37.80%
Key Figures
11.650Open
12.190High
220.57KVolume
5.75P/E TTM
12.30P/E Dynamic
--Dividend TTM
0.37%Turnover Ratio
11.590Prev. Close
10.445Low
2.63MTurnover
LossP/E Static
3.02P/B
0.00%Div Yield TTM
55.05%ROA
15.03552wk High
0.17Volume Ratio
-105.51MNet Profit
59.38MShares
2.1087EPS TTM
0.91Beta
96.08%ROE
8.01052wk Low
15.06%Amplitude
94.41%Gross Margin
720.87MMarket Cap
-1.86Reward/Risk
3.82%Risk Rate
Zevra Therapeutics Inc's Score
0.29vs previous score
Forecast8.67
Financial Health8.74
Technical5.30
Valuation Dimensions7.01
Institutional Confidence5.00
Risk Assessment5.16
Media Coverage
Coverage Level
Very Low
Very High
No data
Analyst Rating
Zevra Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Buy
Moving Average
Strong buy
Zevra Therapeutics Inc Latest Earnings Call Transcripts
Zevra (ZVRA) Q3 2026 Earnings Call: MIPLYFFA Drives 45% Revenue Growth
Zevra’s Q3 2026 earnings call covered 45% revenue growth, $34 million in MIPLYFFA sales, a Q1 2027 sNDA plan and upcoming regulatory milestones.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
0.32/0.16
Revenue / Forecast
37.76M/37.08M
Zevra Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolZVRA
Number of employees59
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 6.99% |
| Woodline Partners LP | 5.84% |
| Vanguard Capital Management, LLC | 4.18% |
| Fidelity Management & Research Company LLC | 3.88% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 25.66% |
| Hedge Fund | 20.29% |
| Investment Advisor/Hedge Fund | 16.33% |
| Research Firm | 4.44% |
Related Instruments
+4.28%
+2.13%
+0.68%
+1.38%
+0.70%
+1.59%
+1.04%
+1.46%
+2.65%
-0.54%
+0.69%
0.00%
-0.14%
+2.30%
+5.83%
+2.40%
+1.73%
+0.33%
+0.95%
+3.78%
FAQs
What is the current price of Zevra Therapeutics Inc (ZVRA)?
The current price of Zevra Therapeutics Inc (ZVRA) is 12.14.
What is the symbol of Zevra Therapeutics Inc?
The ticker symbol of Zevra Therapeutics Inc is ZVRA.
What is the 52-week high of Zevra Therapeutics Inc?
The 52-week high of Zevra Therapeutics Inc is 15.04.
What is the 52-week low of Zevra Therapeutics Inc?
The 52-week low of Zevra Therapeutics Inc is 8.01.
What is the market capitalization of Zevra Therapeutics Inc?
The market capitalization of Zevra Therapeutics Inc is 720.87M.
Is Zevra Therapeutics Inc (ZVRA) currently rated as Buy, Hold, or Sell?
According to analysts, Zevra Therapeutics Inc (ZVRA) has an overall rating of Buy, with a price target of 25.25.
What is the Earnings Per Share (EPS TTM) of Zevra Therapeutics Inc (ZVRA)?
The Earnings Per Share (EPS TTM) of Zevra Therapeutics Inc (ZVRA) is 2.11.